WASHINGTON, D.C. (Tuesday, April 19, 2011) - The Biotechnology Industry Organization (BIO) announced today that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote address at the BIO China International Conference to be held October 12-13 in Shanghai, China. The event will bring together biotechnology and pharmaceutical leaders to explore business opportunities with life science companies in China.
"Dr. Reinhardt is a highly-respected leader within the pharmaceutical industry and international business. Bayer's presence in China and Dr. Reinhardt's knowledge and insights on the market in China will be greatly beneficial to attendees of the BIO China International Conference," said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development.
Dr. Reinhardt has been Chairman of the Board of Management of Bayer HealthCare AG and Chairman of the Bayer HealthCare Executive Committee since August 15, 2010. He started his career with Sandoz, a predecessor company of Novartis, in 1982 and appointed Head of Corporate Development in 1994.
After the formation of Novartis in 1996, he served as Head of Preclinical Development and Project Management before being appointed Global Head of Pharma Development in 1999. In November 2005 he was appointed CEO of the Vaccines & Diagnostics Division in Boston. At the end of 2008, Reinhardt returned to Switzerland to become Chief Operating Officer of Novartis, a position he held until the end of January 2010. From 2000 until January 2010, Reinhardt also served as Chairman of the Board of Directors of the Genomics Institute of the Novartis Foundation in La Jolla, California. From 2001 through 2004 he was a member of the Supervisory Board of MorphoSys AG, Germany.
The BIO China International Conference will feature plenary sessions and workshops on health and regulatory issues, intellectual property, business development and vaccines, and global health. The conference also will include company presentations, partnering meeting opportunities, and an Exhibition. The conference will include biopharmaceutical industry leaders from North America, Europe and Asia.
BIO brings to China more than 15 years of experience in organizing international conferences for the biotech industry, including the BIO International Convention, the world's largest annual biotech conference. BIO is renowned for its successful business development, partnering and investor meetings in North America, Europe and Asia. Partnering at this conference will be powered by BIO One-on-One Partnering™, an interactive environment to intelligently search, contact and schedule private meetings with potential partners and investors.
BIO China is organized by BIO and co-organized by Zhangjiang Hi-Tech Park. For more information on BIO China, please visit http://www.bio.org/biochina/.